Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kiriakos Koukoulias
Observed names:
K. Koukoulias,
KYRIAKOS KOUKOULIAS,
Kyriakos Koukoulias,
Κουκουλιάς, Κυριάκος Γ.,
Κυριάκος Κουκουλιάς
Institutions:
Houston Methodist,
Baylor College of Medicine,
Texas Children's Hospital
Observed institutions:
Houston Methodist,
Baylor College of Medicine,
Aristotle University of Thessaloniki,
Texas Children's Hospital,
G. Papanikolaou General Hospital
ORCID:
0000-0003-0040-0074
Observed ORCID:
0000-0003-0040-0074
OpenAlex ID:
A5108026257
Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers
2017
·
SOFIA LEVVA
, VASSILIKI KOTOULA
, et al.
·
Cancer Genomics & Proteomics
·
48
PDF
Vaccinated and Convalescent Donor–Derived Severe Acute Respiratory Syndrome Coronavirus 2–Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients
2021
·
Penelope-Georgia Papayanni
, Dimitrios Chasiotis
, et al.
·
Clinical Infectious Diseases
·
25
PDF
Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host
2019
·
Anastasia Papadopoulou
, Maria Alvanou
, et al.
·
Bone Marrow Transplantation
·
24
“Cerberus” T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients
2021
·
Kiriakos Koukoulias
, Penelope-Georgia Papayanni
, et al.
·
Frontiers in Immunology
·
10
PDF
Virus-Specific T-Cell Therapy for the Management of Viral Infections in the Immunocompromised
2024
·
Kiriakos Koukoulias
, Penelope Georgia Papayanni
, et al.
·
Transfusion Medicine and Hemotherapy
·
9
PDF
Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity
2021
·
Anastasia Papadopoulou
, Kiriakos Koukoulias
, et al.
·
eJHaem
·
9
Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay
2023
·
Kiriakos Koukoulias
, Penelope G. Papayanni
, et al.
·
Frontiers in Immunology
·
8
PDF
T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy
2023
·
Penelope Georgia Papayanni
, Kiriakos Koukoulias
, et al.
·
British Journal of Haematology
·
8
PDF
Multipathogen-specific T cells against viral and fungal infections
2021
·
Anastasia Papadopoulou
, Kiriakos Koukoulias
, et al.
·
Bone Marrow Transplantation
·
8
High-Throughput T Cell Receptor (TR) Repertoire Analysis of Virus-Specific T Cells: Implications for T Cell Immunotherapy and Viral Infection Risk Stratification
2018
·
Chrysi Galigalidou
, Anastasia Papadopoulou
, et al.
·
Blood
·
6
Evaluating mesothelin as an immunotherapeutic target for endogenous T cells
2026
·
Kiriakos Koukoulias
, Ryu Yanagisawa
, et al.
·
Frontiers in Immunology
·
2
PDF
P1395: Pentavalent-specific T-cells Post Haplo-identical Transplantation for the Treatment of Opportunistic Infections
2023
·
Zoi Bousiou
, Ioannis Kyriakou
, et al.
·
HemaSphere
·
1
Correction to: Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host
2019
·
Anastasia Papadopoulou
, Maria Alvanou
, et al.
·
Bone Marrow Transplantation
·
1
PDF
Non-transplantable cord blood units as a new source for adoptive immunotherapy of leukemia and a paradigm of circular economy in medicine
2017
·
K. Koukoulias
, A. Papadopoulou
, et al.
·
Cytotherapy
·
1
Assessment of the Cytolytic Potential of a Multivirus-Targeted T Cell Therapy Using a Vital Dye-Based, Flow Cytometric Assay
2024
·
Kiriakos Koukoulias
, Penelope G. Papayanni
, et al.
·
Transplantation and Cellular Therapy
Immune Profiling of Respiratory Syncytial Virus (RSV) for the Development of Targeted Immunotherapy
2023
·
Penelope Papayanni
, Kiriakos Koukoulias
, et al.
·
Blood
Υιοθετούμενη ανοσοθεραπεία με αντιγονο-ειδικά Τ-λεμφοκύτταρα έναντι παθογόνων και καρκίνου
2022
·
Κυριάκος Κουκουλιάς
Ps1207 Developing a Crispr‐cas9 Tool to Inactivate the Glucocorticoid Receptor and Broaden the Applicability of Antigen‐specific T‐cell Immunotherapy
2019
·
C. Pantazi
, M. Alvanou
, et al.
·
HemaSphere
Show more works
View as search
Works count:
19
Citation count:
160
H-index:
8
I10-index:
4
Year
Topic
Type